Cisbio international Launches New HTRF? Cell-Based Assays at SBSCompany Expands Integration of d2 Acceptor Molecule to Assays in Inflammation and Metabolic Diseases Fields
Seattle, WA, U.S.A. and Bagnols-sur-C?ze, France ? September 19, 2006 ? Cisbio international, a global developer of HTRF? technology and services used in assay development and drug screen ...
[mehr]
Diesen Artikel bookmarken bei...